furthermore Wu et al. assessed the regulation of p53 expression in lobaplatin signaling pathway.They demonstrated that p53 upregulation was related to E2F1/Rb in lobaplatin treated HCC cells by RT-PCR and western blotting methods. The gene discussed is E2F1; the disease is hepatocellular carcinoma.